CIBC Bancorp USA’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CIBC Bancorp USA's PFE Position: Q3 2026 in Review
CIBC Bancorp USA reduced its Pfizer (PFE) stake by 25% in Q3 2026, selling an estimated $9.7M and leaving 1,109,342 shares worth $31.6M. The position accounts for 0.04% of the portfolio, ranked #326.
CIBC Bancorp USA first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $49.7M in Q1 2026. 2,888 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- CIBC Bancorp USA held 1,109,342 shares of Pfizer worth $31.6M as of Q3 2026.
- CIBC Bancorp USA sold 365,959 Pfizer shares in Q3 2026, an estimated $9.7M.
- Pfizer made up 0.04% of CIBC Bancorp USA's portfolio in Q3 2026, its #326 holding.
- CIBC Bancorp USA first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
- CIBC Bancorp USA's Pfizer position peaked at $49.7M in Q1 2026.
- 2,888 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.